Literature DB >> 9848722

Amyloid goiter due to primary systemic amyloidosis: a diagnostic challenge.

R N Sinha1, J F Plehn, W B Kinlaw.   

Abstract

We describe a euthyroid patient who presented with a goiter that continued to enlarge despite levothyroxine administration. Three fine-needle aspirations for cytology were nondiagnostic. An open biopsy was complicated by bleeding from the surgical site. Primary systemic amyloidosis was diagnosed on the basis of the goiter histology, bone marrow aspirate, and urine immunoelectrophoresis. The patient received melphalan and steroid treatment and survived for an additional 16 months. This period was complicated by congestive heart failure, generalized seizures, and upper gastrointestinal bleeding. Our case illustrates the difficulties in making the diagnosis and in treatment of primary systemic amyloidosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9848722     DOI: 10.1089/thy.1998.8.1051

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  4 in total

1.  Amyloid goiter in a case of systemic amyloidosis secondary to ankylosing spondylitis.

Authors:  P Cohan; S Hirschowitz; J Y Rao; S Tanavoli; A J Van Herle
Journal:  J Endocrinol Invest       Date:  2000-12       Impact factor: 4.256

2.  Amyloid goiter related with Crohn's disease: A rare association: Amyloid goiter secondary to Crohn's disease.

Authors:  Ibrahim Ali Ozemir; Cagri Bilgic; Baris Bayraktar; Sinan Aslan; Ebru Zemheri; Haydar Yalman; Rafet Yigitbasi
Journal:  Int J Surg Case Rep       Date:  2014-06-10

3.  Amyloid accumulation in the toxic nodule of the thyroid gland in a patient with end stage renal failure.

Authors:  Umut Mousa; Sema Aktas; Halit Uner
Journal:  Case Rep Endocrinol       Date:  2012-10-23

4.  Amyloid Goiter in a Patient with Rheumatoid Arthritis and End-Stage Renal Disease.

Authors:  Ayşe Şeker; Taşkin Erkinüresin; Hakan Demirci
Journal:  Indian J Nephrol       Date:  2020-02-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.